CAMP4 THERAPEUTICS
CAMP4 is focused on addressing the fundamental cause of disease by controlling the output of genes central to disease. By taking advantage of the gene circuitry code, CAMP4 is able to control gene production through signaling pathways the cell is already utilizing to regulate gene expression. Their predictions enables CAMP4 to have a rapid start to disease treatment, significantly reducing the time and risk to bring new medicines to patients.
CAMP4 THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.camp4tx.com
Total Employee:
11+
Status:
Active
Contact:
617-651-8867
Email Addresses:
[email protected]
Total Funding:
190 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag Euro
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Amylon Therapeutics
Amylon Therapeutics is a biotechnology company that uses RNA Modulation Technology to target rare genetic disorders.
Amytrx Therapeutics
Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies.
Aptevo Therapeutics
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
BAMF Health
BAMF Health is a biotechnology company that designs, develops, and builds cyclotron-equipped radiopharmacies and clinics.
Casma Therapeutics
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
CB Therapeutics
CB Therapeutics is a biotech company that specializes in the biosynthetic production of cannabinoids from sugar.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
DeepBiome Therapeutics
DeepBiome Therapeutics is an operator of a biotechnology company intended to develop a new drug discovery platform.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Gameto
Gameto is a biotechnology firm focused on female reproductive fertility biotech.
Iksuda Therapeutics
Iksuda Therapeutics is a biotechnology company specializing in the development of next generation biotherapeutics
Nerio Therapeutics
Nerio Therapeutics is a biotechnology company focused on the life sciences sector.
Nirrin Technologies
NIRRIN Analytics is a biotechnology company that develops real-time non-destructive bioprocess monitoring systems.
Novome Biotechnologies
Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.
Parthenon Therapeutics
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Potenza Therapeutics
Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
SIWA Therapeutics
SIWA Therapeutics is a biotechnology company that has a monoclonal antibody that targets and destroys senescent cells.
TreeFrog Therapeutics
TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.
Ventyx Biosciences
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
Vesigen Therapeutics
Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products.
Current Advisors List
Current Employees Featured
Founder
Investors List
The Kraft Group
The Kraft Group investment in Series B - CAMP4 Therapeutics
Enavate Sciences
Enavate Sciences investment in Series B - CAMP4 Therapeutics
Andreessen Horowitz
Andreessen Horowitz investment in Series B - CAMP4 Therapeutics
Gaingels
Gaingels investment in Series B - CAMP4 Therapeutics
Polaris Partners
Polaris Partners investment in Series B - CAMP4 Therapeutics
Northpond Ventures
Northpond Ventures investment in Series B - CAMP4 Therapeutics
5AM Ventures
5AM Ventures investment in Series B - CAMP4 Therapeutics
Polaris Partners
Polaris Partners investment in Series A - CAMP4 Therapeutics
The Kraft Group
The Kraft Group investment in Series A - CAMP4 Therapeutics
5AM Ventures
5AM Ventures investment in Series A - CAMP4 Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-19 | CAMP4 Therapeutics Promotes Kelly Gold to Chief Financial Officer |
Official Site Inspections
http://www.camp4tx.com Semrush global rank: 3.87 M Semrush visits lastest month: 3.35 K
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CAMP4 Therapeutics"
Leadership • CAMP4
Oct 11, 2024 Director, Stem Cell Program, Boston Children’s Hospital; Grousbeck Professor of Pediatrics, Harvard Medical School; Investigator, Howard Hughes Medical InstituteSee details»
CAMP4 Therapeutics - Crunchbase Company Profile
Organization. CAMP4 Therapeutics . Connect to CRM . Save . Summary. …See details»
Camp4 Therapeutics Org Chart + Executive Team - The Official …
Organizational Chart of Camp4 Therapeutics. Camp4 Therapeutics Org Chart www.camp4tx.com. has 24 executives +1 617651 8867See details»
CAMP4 Therapeutics - Overview, News & Similar companies
CAMP4 Therapeutics contact info: Phone number: (617) 651-8867 Website: www.camp4tx.com What does CAMP4 Therapeutics do? At CAMP4 Therapeutics, we are revolutionizing drug …See details»
CAMP4 Therapeutics Expands Leadership and Board of Directors
Jul 13, 2021 While there, Ms. Gates played a pivotal role in contributing to massive growth and global expansion of the organization, including several acquisitions, and talent driven initiatives …See details»
CAMP4
CAMP4 is a biotech company developing ASO therapeutics to enhance gene expression, targeting genetic diseases with innovative approaches and advanced drug discovery methods.See details»
CAMP4 Secures $100 Million Series B Financing to ... - Enavate …
Jul 20, 2022 Learn more about us at www.CAMP4tx.com and follow us @CAMP4tx. About Enavate Sciences Enavate Sciences is a platform created by Patient Square Capital dedicated …See details»
Camp4 Therapeutics Corporation | CipherBio
Explore Camp4 Therapeutics Corporation's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
CAMP4 Therapeutics Expands Leadership and Board of Directors
Jul 13, 2021 Prior to joining CAMP4, Ms. Gold held various roles in corporate finance and business planning at Biogen, where she provided financial leadership for the company’s late …See details»
CAMP4 Therapeutics Overview | SignalHire Company Profile
CAMP4 Therapeutics is a private company that has been in the industry for 9 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is …See details»
Release Details - investors.camp4tx.com
Mar 27, 2025 For more information, visit camp4tx.com. Forward-Looking Statements This press release contains forward-looking statements which involve risks, uncertainties and …See details»
Why CAMP4? • CAMP4 - camp4tx.com
Oct 11, 2024 At CAMP4, we are pioneering a novel approach to programmable ASO therapeutics. Our RAP platform’s proprietary insights enable us to rapidly discover and …See details»
CAMP4 Secures $100 Million Series B Financing to Accelerate …
Jul 20, 2022 Learn more about us at www.CAMP4tx.com and follow us @CAMP4tx. About Enavate Sciences Enavate Sciences is a platform created by Patient Square Capital dedicated …See details»
Contact Us - CAMP4
Oct 11, 2024 One Kendall Square Bldg 1400 West, 3rd Floor Cambridge, MA 02139See details»
News Releases • CAMP4 Therapeutics - investors.camp4tx.com
Apr 28, 2025 Phase 1 clinical trial of CMP-CPS-001 in Urea Cycle Disorders (UCDs) ongoing, with dosing completed in multiple ascending dose (MAD) cohort 3; safety, pharmacokinetic, …See details»
Camp4 Raises $100 Million in Series B - The SaaS News
Jul 21, 2022 The round was led by Enavate Sciences, a portfolio company created by Patient Square Capital, with participation from a large national managed care organization and the …See details»
CAMP4 Reports First Quarter 2025 Financial Results and Corporate ...
May 13, 2025 For more information, visit camp4tx.com. Forward-Looking Statements This press release contains forward-looking statements which involve risks, uncertainties and …See details»
Press Releases • CAMP4 - camp4tx.com
Oct 11, 2024 Camp4 CEO credits CFO, investors’ ‘risk appetite’ for IPO. Read More. Contact Us; Privacy Policy; Terms of UseSee details»
Join the Adventure • CAMP4 - camp4tx.com
Oct 11, 2024 If you don’t see any current job openings that match your skill set, submit your resume to [email protected] and tell us why you’d like to join the adventure. Note to …See details»
About Our Name • CAMP4 - camp4tx.com
Oct 11, 2024 CAMP4 is the final camp before a climber’s final ascent to the summit of Mt. Everest. CAMP4 is also a sacred climbing haven in Yosemite where the greatest climbers …See details»